AKT1 and acute myeloid leukemia: Dysregulation of the PI3K-Akt-mTOR signaling pathway subsequent to oncogene activating mutations, oncogene amplification, upstream activation of RTKs, or inactivation of tumor suppressor genes has been demonstrated in many human malignancies, including AML [79,80].